stockrowAxsome Therapeutics, Inc. (AXSM) vs Ligand Pharmaceuticals Incorporated (LGND)
- Axsome Therapeutics, Inc. AXSM 132.46 +2.05%
- Ligand Pharmaceuticals Incorporated LGND 306.49 +2.51%
Axsome Therapeutics, Inc. and Ligand Pharmaceuticals Incorporated are both Biotechnology companies. Axsome Therapeutics, Inc. is the larger, with a market value of $6.8B against $6.0B — 1.1× the size. Axsome Therapeutics, Inc. has negative trailing earnings, so its P/E is not meaningful; Ligand Pharmaceuticals Incorporated trades at 116×. Axsome Therapeutics, Inc. grew revenue faster over the last twelve months: 54.2% against 1.03%. Ligand Pharmaceuticals Incorporated has the higher net margin (20.3% vs −18.2%) and the higher return on invested capital (1.27% vs 0.00%). Across the 17 metrics below, Ligand Pharmaceuticals Incorporated leads on 13 and Axsome Therapeutics, Inc. on 4.
Valuation
Profitability
| Metric | AXSM | LGND | Biotechnology median |
|---|---|---|---|
| Gross margin | 93.25% | 95.22% | 65.16% |
| Operating margin | (17.45%) | 9.29% | 0.00% |
| Net margin | (18.18%) | 20.27% | 0.00% |
| Free cash flow margin | (9.55%) | 31.43% | 0.00% |
| Return on equity | (175.59%) | 5.38% | (50.12%) |
| Return on assets | (21.03%) | 2.77% | (45.60%) |
| Return on invested capital | 0.00% | 1.27% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack